Director/PDMR Shareholding

Fevara

15/12/2025 18:30

RNS Number : 6573L

Fevara PLC

15 December 2025

 

 

Fevara plc

("Fevara", the "Company", or the "Group")

Director/PDMR Shareholdings

Fevara plc (LSE: FVA), an international specialist in livestock supplements, announces that the following award of options ("Options") was made on 11 December 2025 over ordinary shares in the Company of 2.5p each ("Ordinary Shares"), being the deferral into shares of 25% of an annual cash bonus, as required by the Directors' Remuneration Policy.  The award is made subject to the Company's Deferred Bonus Share Plan 2023 (the "DBSP"), with a vesting period of two years.

 

PDMR
Number of Ordinary Shares
subject to Options
Joshua Hoopes
8,183


.

The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):

 

1
. Details of the person discharging managerial responsibilities/person closely associated
a) Name
Joshua Hoopes
2
. Reason for the notification
a) Position/status
Chief Executive Officer
b) Initial notification/Amendment
Initial Notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Fevara plc
b) LEI
213800HTIKPQV98RA653
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Ordinary Shares of £0.025 each
b) Identification Code
GB00BRK01058
c) Nature of transactions
Grant of Award
d) Price(s) and Volume(s)
Price(s)
Nil-Cost
Volume(s)
8,183
e) Aggregated information:
i. Aggregated volume
ii. price
N/A
f) Date of the transaction
11 December 2025
g) Place of the transaction
Outside trading venue

 

Enquiries:

Fevara plc
 Fiona Rodford (Remuneration Committee Chair)
Paula Robertson (Company Secretary)
01228 554 600


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBIBDDCDBDGUU